The world has been fixated for months on novel-coronavirus PCR testing, contact tracing and vaccination.
Meanwhile, another major part of the Covid biomedical complex has received far less attention: the use of antibodies for detecting, diagnosing and treating infection with the novel coronavirus.
Hundreds of antibodies have been approved for these purposes since January 2020. And hundreds more are poised to start being marketed soon.
This is part of the biomedical gold rush: by last summer already, antibodies were on track to become the most lucrative medical product, with global revenue projected to reach nearly half a trillion dollars by 2024.
Profit margins in the range of
As COVID-19 vaccines and full inoculations become more common, Dr. Anthony Fauci outlined under which conditions people can stop wearing face masks.Face masks have been an integral part of stopping the spread of COVID-19. Wearing the perso…
COVID-19: This Is When We Can All Stop Wearing Masks, Fauci Says dailyvoice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyvoice.com Daily Mail and Mail on Sunday newspapers.
Coronavirus News Roundup: February 27–March 5 - Scientific American scientificamerican.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scientificamerican.com Daily Mail and Mail on Sunday newspapers.